Cerus Corporation CERS was a big mover last session with its shares rising nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained over 10% in the past one-month time frame.
This biomedical products company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Cerus currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Some better-ranked stocks worth considering in the medical products industry are ICU Medical, Inc. ICUI, Abaxis, Inc. ABAX and Eagle Pharmaceuticals Inc. EGRX. While ICU Medical sports a Zacks Rank #1 (Strong Buy), Abaxis and Eagle Pharmaceuticals carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
This biomedical products company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Cerus currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Some better-ranked stocks worth considering in the medical products industry are ICU Medical, Inc. ICUI, Abaxis, Inc. ABAX and Eagle Pharmaceuticals Inc. EGRX. While ICU Medical sports a Zacks Rank #1 (Strong Buy), Abaxis and Eagle Pharmaceuticals carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CERUS CORP CERS: Free Stock Analysis Report
ICU MEDICAL INC ICUI: Free Stock Analysis Report
ABAXIS INC ABAX: Free Stock Analysis Report
EAGLE PHARMACT EGRX: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
